🟢 Edesa Biotech is trading 5.45% up today after rebounding from $25 million offering-driven selling

Edesa Biotech is trading at $4.64 with a +5.45% gain as it rebounds from heavy selling triggered by its $25 million public offering.

• The financing was priced at $5.50 per common-share unit and includes common shares, pre-funded warrants, and accompanying warrants.
• The August 25, 2026 gain appears to reflect recovery from the offering-driven decline, with broader biotechnology strength adding support; the sector is up 2.06% during regular trading.